Structure

Physi-Chem Properties

Molecular Weight:  388.17
Volume:  409.607
LogP:  6.416
LogD:  5.183
LogS:  -4.284
# Rotatable Bonds:  1
TPSA:  44.76
# H-Bond Aceptor:  4
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.623
Synthetic Accessibility Score:  3.666
Fsp3:  0.32
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.678
MDCK Permeability:  1.4477057447948027e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.008
20% Bioavailability (F20%):  0.475
30% Bioavailability (F30%):  0.446

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.031
Plasma Protein Binding (PPB):  100.15230560302734%
Volume Distribution (VD):  0.571
Pgp-substrate:  1.4828722476959229%

ADMET: Metabolism

CYP1A2-inhibitor:  0.596
CYP1A2-substrate:  0.715
CYP2C19-inhibitor:  0.945
CYP2C19-substrate:  0.451
CYP2C9-inhibitor:  0.95
CYP2C9-substrate:  0.9
CYP2D6-inhibitor:  0.957
CYP2D6-substrate:  0.699
CYP3A4-inhibitor:  0.928
CYP3A4-substrate:  0.524

ADMET: Excretion

Clearance (CL):  3.95
Half-life (T1/2):  0.07

ADMET: Toxicity

hERG Blockers:  0.828
Human Hepatotoxicity (H-HT):  0.971
Drug-inuced Liver Injury (DILI):  0.842
AMES Toxicity:  0.042
Rat Oral Acute Toxicity:  0.856
Maximum Recommended Daily Dose:  0.332
Skin Sensitization:  0.085
Carcinogencity:  0.932
Eye Corrosion:  0.003
Eye Irritation:  0.025
Respiratory Toxicity:  0.937

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC59522

Natural Product ID:  NPC59522
Common Name*:   Xambioona
IUPAC Name:   (2S)-2-(2,2-dimethylchromen-6-yl)-8,8-dimethyl-2,3-dihydropyrano[2,3-f]chromen-4-one
Synonyms:  
Standard InCHIKey:  FGJUXFVUOCKRCY-QFIPXVFZSA-N
Standard InCHI:  InChI=1S/C25H24O4/c1-24(2)11-9-16-13-15(5-7-20(16)28-24)22-14-19(26)17-6-8-21-18(23(17)27-22)10-12-25(3,4)29-21/h5-13,22H,14H2,1-4H3/t22-/m0/s1
SMILES:  O=C1C[C@H](Oc2c1ccc1c2C=CC(O1)(C)C)c1ccc2c(c1)C=CC(O2)(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2437375
PubChem CID:   73352581
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0003520] Pyranoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota Leaves n.a. n.a. PMID[12713396]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota roots n.a. n.a. PMID[20022509]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[21866899]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[23325115]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota Roots n.a. n.a. PMID[23541646]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[28140583]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[7381508]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO29384 Glycyrrhiza glabra Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens Inhibition < 50.0 % PMID[504780]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens Inhibition = 76.9 % PMID[504781]
NPT152 Individual Protein Nuclear factor erythroid 2-related factor 2 Homo sapiens FC = 1.8 n.a. PMID[504781]
NPT113 Cell Line RAW264.7 Mus musculus Inhibition = 6.9 % PMID[504781]
NPT65 Cell Line HepG2 Homo sapiens Inhibition = 0.0 % PMID[504781]
NPT81 Cell Line A549 Homo sapiens Inhibition = 10.9 % PMID[504781]
NPT83 Cell Line MCF7 Homo sapiens Inhibition = 0.0 % PMID[504781]
NPT660 Cell Line SW480 Homo sapiens Inhibition = 7.9 % PMID[504781]
NPT741 Individual Protein Tyrosinase Homo sapiens Inhibition = 0.0 % PMID[504781]
NPT2 Others Unspecified Inhibition = 0.0 % PMID[504781]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC59522 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9854 High Similarity NPC52576
0.9781 High Similarity NPC472409
0.9708 High Similarity NPC11566
0.9643 High Similarity NPC179970
0.9635 High Similarity NPC17848
0.9577 High Similarity NPC161191
0.9562 High Similarity NPC157855
0.9562 High Similarity NPC259685
0.9507 High Similarity NPC218300
0.9507 High Similarity NPC282335
0.9507 High Similarity NPC23728
0.9507 High Similarity NPC110303
0.95 High Similarity NPC147145
0.9489 High Similarity NPC161196
0.9441 High Similarity NPC160821
0.9441 High Similarity NPC189087
0.9441 High Similarity NPC321623
0.9441 High Similarity NPC132592
0.9437 High Similarity NPC214774
0.9437 High Similarity NPC176229
0.9437 High Similarity NPC111786
0.9437 High Similarity NPC67805
0.9437 High Similarity NPC301276
0.9437 High Similarity NPC312973
0.9437 High Similarity NPC195621
0.9437 High Similarity NPC88964
0.9437 High Similarity NPC475052
0.9437 High Similarity NPC470647
0.9437 High Similarity NPC54577
0.9437 High Similarity NPC246948
0.9437 High Similarity NPC83357
0.9437 High Similarity NPC142405
0.9437 High Similarity NPC267375
0.9437 High Similarity NPC20488
0.9416 High Similarity NPC99854
0.9416 High Similarity NPC46869
0.9371 High Similarity NPC237635
0.9371 High Similarity NPC296998
0.9371 High Similarity NPC473077
0.9371 High Similarity NPC79469
0.9371 High Similarity NPC24673
0.9371 High Similarity NPC201731
0.9371 High Similarity NPC97716
0.9371 High Similarity NPC104406
0.9371 High Similarity NPC283234
0.9366 High Similarity NPC319752
0.9366 High Similarity NPC209040
0.9348 High Similarity NPC254741
0.9343 High Similarity NPC125269
0.932 High Similarity NPC477530
0.9306 High Similarity NPC6511
0.9306 High Similarity NPC266572
0.9301 High Similarity NPC476088
0.9301 High Similarity NPC474161
0.9296 High Similarity NPC150408
0.9296 High Similarity NPC143896
0.9296 High Similarity NPC310130
0.9296 High Similarity NPC39329
0.9296 High Similarity NPC221432
0.9296 High Similarity NPC68104
0.9296 High Similarity NPC91560
0.9296 High Similarity NPC75049
0.9296 High Similarity NPC164980
0.9296 High Similarity NPC478086
0.9296 High Similarity NPC149026
0.9296 High Similarity NPC214166
0.9296 High Similarity NPC257097
0.9296 High Similarity NPC169591
0.9296 High Similarity NPC38219
0.9296 High Similarity NPC316816
0.9296 High Similarity NPC175504
0.9291 High Similarity NPC103362
0.9291 High Similarity NPC22467
0.9241 High Similarity NPC5173
0.9241 High Similarity NPC164299
0.9236 High Similarity NPC471285
0.9231 High Similarity NPC473013
0.9231 High Similarity NPC131568
0.9231 High Similarity NPC131579
0.9231 High Similarity NPC236766
0.9231 High Similarity NPC473015
0.9231 High Similarity NPC197252
0.9225 High Similarity NPC194432
0.9225 High Similarity NPC125855
0.9225 High Similarity NPC296917
0.9225 High Similarity NPC76372
0.9225 High Similarity NPC66515
0.9225 High Similarity NPC161506
0.9225 High Similarity NPC228504
0.9225 High Similarity NPC148757
0.9225 High Similarity NPC59739
0.9225 High Similarity NPC293852
0.9225 High Similarity NPC78
0.9225 High Similarity NPC166482
0.9225 High Similarity NPC10937
0.9225 High Similarity NPC220998
0.9225 High Similarity NPC177354
0.9225 High Similarity NPC182852
0.9225 High Similarity NPC64915
0.9225 High Similarity NPC167624
0.9225 High Similarity NPC107572
0.9225 High Similarity NPC299080
0.9225 High Similarity NPC226636
0.9225 High Similarity NPC11561
0.9225 High Similarity NPC166934
0.9225 High Similarity NPC223500
0.9225 High Similarity NPC1089
0.9225 High Similarity NPC217083
0.9225 High Similarity NPC214236
0.9225 High Similarity NPC78803
0.9225 High Similarity NPC37496
0.9225 High Similarity NPC32739
0.9225 High Similarity NPC40833
0.9225 High Similarity NPC324436
0.9225 High Similarity NPC227579
0.9225 High Similarity NPC62840
0.9225 High Similarity NPC328164
0.9225 High Similarity NPC265040
0.9225 High Similarity NPC76338
0.9225 High Similarity NPC324134
0.9225 High Similarity NPC306829
0.922 High Similarity NPC150522
0.9197 High Similarity NPC473655
0.9197 High Similarity NPC101294
0.9197 High Similarity NPC229646
0.9184 High Similarity NPC40033
0.9178 High Similarity NPC5840
0.9178 High Similarity NPC472633
0.9178 High Similarity NPC189270
0.9178 High Similarity NPC188403
0.9167 High Similarity NPC470131
0.9167 High Similarity NPC470134
0.9167 High Similarity NPC473078
0.9167 High Similarity NPC470132
0.9167 High Similarity NPC109183
0.9167 High Similarity NPC285630
0.9167 High Similarity NPC127059
0.9167 High Similarity NPC470133
0.9161 High Similarity NPC166138
0.9161 High Similarity NPC107177
0.9161 High Similarity NPC18585
0.9161 High Similarity NPC85162
0.9161 High Similarity NPC77794
0.9161 High Similarity NPC278249
0.9161 High Similarity NPC106985
0.9161 High Similarity NPC185276
0.9161 High Similarity NPC81697
0.9161 High Similarity NPC125894
0.9161 High Similarity NPC223812
0.9161 High Similarity NPC219915
0.9155 High Similarity NPC279650
0.9155 High Similarity NPC147688
0.9155 High Similarity NPC201820
0.9155 High Similarity NPC17170
0.9155 High Similarity NPC248372
0.9155 High Similarity NPC64908
0.9155 High Similarity NPC166689
0.9155 High Similarity NPC110038
0.9155 High Similarity NPC156590
0.9155 High Similarity NPC4743
0.9155 High Similarity NPC96408
0.9155 High Similarity NPC118840
0.9155 High Similarity NPC3188
0.9155 High Similarity NPC324386
0.9155 High Similarity NPC213322
0.9155 High Similarity NPC205006
0.9155 High Similarity NPC258630
0.9155 High Similarity NPC110969
0.9155 High Similarity NPC312391
0.9155 High Similarity NPC156190
0.913 High Similarity NPC292998
0.913 High Similarity NPC223354
0.9124 High Similarity NPC278556
0.9124 High Similarity NPC284424
0.9122 High Similarity NPC223701
0.9122 High Similarity NPC7989
0.9122 High Similarity NPC88983
0.9122 High Similarity NPC472583
0.911 High Similarity NPC104236
0.911 High Similarity NPC164205
0.911 High Similarity NPC473016
0.911 High Similarity NPC3642
0.9103 High Similarity NPC472627
0.9097 High Similarity NPC470135
0.9097 High Similarity NPC473014
0.9097 High Similarity NPC470136
0.9097 High Similarity NPC124780
0.9097 High Similarity NPC39045
0.9097 High Similarity NPC234629
0.9097 High Similarity NPC87486
0.9097 High Similarity NPC235217
0.9097 High Similarity NPC171656
0.9097 High Similarity NPC311741
0.9091 High Similarity NPC144499
0.9085 High Similarity NPC172986
0.9085 High Similarity NPC235239
0.9085 High Similarity NPC110228
0.9085 High Similarity NPC171094
0.9085 High Similarity NPC159275
0.9085 High Similarity NPC188243

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC59522 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9348 High Similarity NPD2796 Approved
0.8966 High Similarity NPD7410 Clinical (unspecified phase)
0.8944 High Similarity NPD1549 Phase 2
0.8873 High Similarity NPD1552 Clinical (unspecified phase)
0.8873 High Similarity NPD1550 Clinical (unspecified phase)
0.8859 High Similarity NPD7411 Suspended
0.8836 High Similarity NPD4378 Clinical (unspecified phase)
0.8792 High Similarity NPD4380 Phase 2
0.8742 High Similarity NPD7096 Clinical (unspecified phase)
0.8684 High Similarity NPD8443 Clinical (unspecified phase)
0.8675 High Similarity NPD6801 Discontinued
0.8618 High Similarity NPD2393 Clinical (unspecified phase)
0.8618 High Similarity NPD7819 Suspended
0.8601 High Similarity NPD1510 Phase 2
0.8581 High Similarity NPD5494 Approved
0.8571 High Similarity NPD7075 Discontinued
0.8514 High Similarity NPD6799 Approved
0.8452 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8451 Intermediate Similarity NPD1240 Approved
0.8367 Intermediate Similarity NPD1243 Approved
0.8365 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8345 Intermediate Similarity NPD3748 Approved
0.8344 Intermediate Similarity NPD920 Approved
0.8344 Intermediate Similarity NPD5403 Approved
0.8333 Intermediate Similarity NPD5401 Approved
0.8333 Intermediate Similarity NPD1607 Approved
0.8323 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8322 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.8321 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.8312 Intermediate Similarity NPD1934 Approved
0.8301 Intermediate Similarity NPD6599 Discontinued
0.8291 Intermediate Similarity NPD6959 Discontinued
0.8243 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8212 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.8153 Intermediate Similarity NPD7768 Phase 2
0.8137 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD6166 Phase 2
0.8089 Intermediate Similarity NPD3817 Phase 2
0.8067 Intermediate Similarity NPD3750 Approved
0.8056 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8042 Intermediate Similarity NPD6832 Phase 2
0.8026 Intermediate Similarity NPD1511 Approved
0.8025 Intermediate Similarity NPD2801 Approved
0.7988 Intermediate Similarity NPD7054 Approved
0.7987 Intermediate Similarity NPD3749 Approved
0.7975 Intermediate Similarity NPD5402 Approved
0.7939 Intermediate Similarity NPD7074 Phase 3
0.7939 Intermediate Similarity NPD7472 Approved
0.7937 Intermediate Similarity NPD919 Approved
0.7925 Intermediate Similarity NPD3882 Suspended
0.7922 Intermediate Similarity NPD1512 Approved
0.7892 Intermediate Similarity NPD6797 Phase 2
0.7891 Intermediate Similarity NPD5124 Phase 1
0.7891 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7852 Intermediate Similarity NPD2799 Discontinued
0.7844 Intermediate Similarity NPD7251 Discontinued
0.784 Intermediate Similarity NPD1247 Approved
0.7818 Intermediate Similarity NPD3818 Discontinued
0.7812 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7808 Intermediate Similarity NPD2313 Discontinued
0.78 Intermediate Similarity NPD1551 Phase 2
0.7798 Intermediate Similarity NPD7808 Phase 3
0.7785 Intermediate Similarity NPD5889 Approved
0.7785 Intermediate Similarity NPD5890 Approved
0.7771 Intermediate Similarity NPD5844 Phase 1
0.7763 Intermediate Similarity NPD2800 Approved
0.7738 Intermediate Similarity NPD6559 Discontinued
0.7733 Intermediate Similarity NPD7033 Discontinued
0.7722 Intermediate Similarity NPD6585 Discontinued
0.7718 Intermediate Similarity NPD6651 Approved
0.7697 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7682 Intermediate Similarity NPD2935 Discontinued
0.7679 Intermediate Similarity NPD5953 Discontinued
0.7665 Intermediate Similarity NPD7286 Phase 2
0.7655 Intermediate Similarity NPD2798 Approved
0.7651 Intermediate Similarity NPD1933 Approved
0.7647 Intermediate Similarity NPD2654 Approved
0.7636 Intermediate Similarity NPD3926 Phase 2
0.7622 Intermediate Similarity NPD3972 Approved
0.7597 Intermediate Similarity NPD4628 Phase 3
0.7597 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7588 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD3266 Approved
0.7586 Intermediate Similarity NPD3267 Approved
0.7584 Intermediate Similarity NPD4307 Phase 2
0.7557 Intermediate Similarity NPD4363 Phase 3
0.7557 Intermediate Similarity NPD4360 Phase 2
0.7551 Intermediate Similarity NPD4908 Phase 1
0.7536 Intermediate Similarity NPD1241 Discontinued
0.7533 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD2532 Approved
0.7516 Intermediate Similarity NPD2344 Approved
0.7516 Intermediate Similarity NPD2346 Discontinued
0.7516 Intermediate Similarity NPD2534 Approved
0.7516 Intermediate Similarity NPD2533 Approved
0.7472 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD6232 Discontinued
0.7466 Intermediate Similarity NPD1203 Approved
0.7453 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD6100 Approved
0.7451 Intermediate Similarity NPD6099 Approved
0.745 Intermediate Similarity NPD1296 Phase 2
0.745 Intermediate Similarity NPD3268 Approved
0.744 Intermediate Similarity NPD7473 Discontinued
0.7438 Intermediate Similarity NPD3226 Approved
0.7436 Intermediate Similarity NPD3295 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD3887 Approved
0.7415 Intermediate Similarity NPD1019 Discontinued
0.7397 Intermediate Similarity NPD3225 Approved
0.7396 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD1548 Phase 1
0.7386 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD4308 Phase 3
0.7379 Intermediate Similarity NPD9717 Approved
0.7372 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD3142 Approved
0.7351 Intermediate Similarity NPD3140 Approved
0.7347 Intermediate Similarity NPD2797 Approved
0.7345 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD7390 Discontinued
0.7329 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD7458 Discontinued
0.7325 Intermediate Similarity NPD2309 Approved
0.7317 Intermediate Similarity NPD4288 Approved
0.731 Intermediate Similarity NPD1610 Phase 2
0.7301 Intermediate Similarity NPD6844 Discontinued
0.7297 Intermediate Similarity NPD7584 Approved
0.7296 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD3751 Discontinued
0.729 Intermediate Similarity NPD1471 Phase 3
0.7262 Intermediate Similarity NPD3787 Discontinued
0.7237 Intermediate Similarity NPD943 Approved
0.7225 Intermediate Similarity NPD6104 Discontinued
0.7222 Intermediate Similarity NPD4361 Phase 2
0.7222 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6798 Discontinued
0.7209 Intermediate Similarity NPD1729 Discontinued
0.7195 Intermediate Similarity NPD6280 Approved
0.7195 Intermediate Similarity NPD6279 Approved
0.7192 Intermediate Similarity NPD422 Phase 1
0.7188 Intermediate Similarity NPD4661 Approved
0.7188 Intermediate Similarity NPD4662 Approved
0.7179 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD2353 Approved
0.7176 Intermediate Similarity NPD2403 Approved
0.7172 Intermediate Similarity NPD17 Approved
0.7162 Intermediate Similarity NPD1876 Approved
0.716 Intermediate Similarity NPD6808 Phase 2
0.7152 Intermediate Similarity NPD1465 Phase 2
0.7152 Intermediate Similarity NPD4625 Phase 3
0.7152 Intermediate Similarity NPD8455 Phase 2
0.7152 Intermediate Similarity NPD7003 Approved
0.7143 Intermediate Similarity NPD8312 Approved
0.7143 Intermediate Similarity NPD8313 Approved
0.7134 Intermediate Similarity NPD2424 Discontinued
0.7125 Intermediate Similarity NPD7212 Phase 2
0.7125 Intermediate Similarity NPD7213 Phase 3
0.7104 Intermediate Similarity NPD8285 Discontinued
0.7091 Intermediate Similarity NPD7577 Discontinued
0.7089 Intermediate Similarity NPD1652 Phase 2
0.7086 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD5019 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD6780 Approved
0.7065 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD6778 Approved
0.7065 Intermediate Similarity NPD6782 Approved
0.7065 Intermediate Similarity NPD6781 Approved
0.7065 Intermediate Similarity NPD6777 Approved
0.7065 Intermediate Similarity NPD6776 Approved
0.7065 Intermediate Similarity NPD6779 Approved
0.7059 Intermediate Similarity NPD5710 Approved
0.7059 Intermediate Similarity NPD7229 Phase 3
0.7059 Intermediate Similarity NPD5711 Approved
0.7039 Intermediate Similarity NPD4287 Approved
0.7037 Intermediate Similarity NPD5049 Phase 3
0.7037 Intermediate Similarity NPD6273 Approved
0.7034 Intermediate Similarity NPD9545 Approved
0.7027 Intermediate Similarity NPD1608 Approved
0.7013 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD1613 Approved
0.7 Intermediate Similarity NPD2354 Approved
0.6994 Remote Similarity NPD5940 Clinical (unspecified phase)
0.6987 Remote Similarity NPD7097 Phase 1
0.6986 Remote Similarity NPD1651 Approved
0.6975 Remote Similarity NPD7447 Phase 1
0.6972 Remote Similarity NPD5535 Approved
0.6971 Remote Similarity NPD3823 Discontinued
0.6968 Remote Similarity NPD6355 Discontinued
0.6952 Remote Similarity NPD7696 Phase 3
0.6952 Remote Similarity NPD7698 Approved
0.6952 Remote Similarity NPD7435 Discontinued
0.6952 Remote Similarity NPD7697 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data